A recent article in Industrial Info Resources, reported by Annette Kreuger, stated that the final construction tally is in for 2011, and they say that the numbers are encouraging.
“Despite the myriad challenges facing the Pharmaceutical-Biotech Industry as it continues its massive reorganization, the sector managed to kick off construction on $12.1 billion in capital and maintenance projects in 2011. That amount was divided among the 702 projects that made it into active construction. This number may possibly go even higher, as new projects are uncovered that began construction in 2011 and still have opportunities remaining.”
For more details or to view the entire article, you can subscribe to Industrial Info's Premium Industry News at http://www.industrialinfo.com... Read More